Achieve Life Sciences
ACHV
ACHV
30 hedge funds and large institutions have $11.2M invested in Achieve Life Sciences in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 8 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
43% less call options, than puts
Call options by funds: $120K | Put options by funds: $209K
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Holders
30
Holding in Top 10
–
Calls
$120K
Puts
$209K
Top Buyers
| 1 | +$278K | |
| 2 | +$202K | |
| 3 | +$94.9K | |
| 4 |
LPL Financial
San Diego,
California
|
+$57.7K |
| 5 |
Walleye Capital
New York
|
+$53.3K |
Top Sellers
| 1 | -$1.17M | |
| 2 | -$538K | |
| 3 | -$249K | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$210K |
| 5 |
PCM
Prelude Capital Management
New York
|
-$109K |